PRO-DEX, INC. Increase (Decrease) in Unbilled Receivables
PRO-DEX, INC. (PDEX) reported Increase (Decrease) in Unbilled Receivables of -$730.00 thousand for the 9-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Notes
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2016-05-12
- PRO-DEX, INC. increase (decrease) in unbilled receivables for the quarter ending 2016-03-31 was $15.00K.
- PRO-DEX, INC. increase (decrease) in unbilled receivables for the quarter ending 2015-12-31 was -$986.00K, a 627.27% decline year-over-year.
- PRO-DEX, INC. increase (decrease) in unbilled receivables for the quarter ending 2015-09-30 was $241.00K, a 55.48% increase year-over-year.
- PRO-DEX, INC. increase (decrease) in unbilled receivables for the quarter ending 2015-06-30 was -$544.00K, a 835.14% decline year-over-year.
- PRO-DEX, INC. increase (decrease) in unbilled receivables for fiscal 2015 was -$220.00K, a 126.57% decline from fiscal 2014.
- PRO-DEX, INC. increase (decrease) in unbilled receivables for fiscal 2014 was $828.00K, a 239.34% increase from fiscal 2013.
- PRO-DEX, INC. increase (decrease) in unbilled receivables for fiscal 2013 was $244.00K.
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 6 month | Increase (Decrease) in Unbilled Receivables 9 month | Increase (Decrease) in Unbilled Receivables 12 month |
|---|---|---|---|---|
| 2016-03-31 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | -$971.00K derived: sum of 2 quarters · filed 2016-05-12 | -$730.00K 10-Q · filed 2016-05-12 | -$1.27M derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-12-31 | -$986.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-11 | -$745.00K 10-Q · filed 2016-02-11 | -$1.29M derived: sum of 3 quarters · filed 2016-02-11 | -$1.31M derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-09-30 | $241.00K 10-Q · filed 2015-11-10 | -$303.00K derived: sum of 2 quarters · filed 2015-11-10 | -$321.00K derived: sum of 3 quarters · filed 2016-05-12 | -$134.00K derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-06-30 | -$544.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-17 | -$562.00K derived: sum of 2 quarters · filed 2016-05-12 | -$375.00K derived: sum of 3 quarters · filed 2016-05-12 | -$220.00K 10-K · filed 2015-09-17 |
| 2015-03-31 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | $169.00K derived: sum of 2 quarters · filed 2016-05-12 | $324.00K 10-Q · filed 2016-05-12 | $398.00K derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | $187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-11 | $342.00K 10-Q · filed 2016-02-11 | $416.00K derived: sum of 3 quarters · filed 2016-02-11 | $803.00K derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-09-30 | $155.00K 10-Q · filed 2015-11-10 | $229.00K derived: sum of 2 quarters · filed 2015-11-10 | $616.00K derived: sum of 3 quarters · filed 2015-11-10 | $829.00K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-17 | $461.00K derived: sum of 2 quarters · filed 2015-09-17 | $674.00K derived: sum of 3 quarters · filed 2015-09-17 | $828.00K 10-K · filed 2015-09-17 |
| 2014-03-31 | $387.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-14 | $600.00K derived: sum of 2 quarters · filed 2015-05-14 | $754.00K 10-Q · filed 2015-05-14 | |
| 2013-12-31 | $213.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-10 | $367.00K 10-Q · filed 2015-02-10 | ||
| 2013-09-30 | $154.00K 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | $244.00K 10-K · filed 2014-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |